Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

ELI LILLY AND COMPANY

(LLY)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur ELI LILLY AND COMPANY
03/12FDA adds strict safety warnings on arthritis drugs from Pfizer, AbbVie and Lilly
03/12Eli Lilly, AbCellera Land FDA's Expanded Emergency Use Approval for COVID-19 Antibody T..
03/12Eli Lilly Gets FDA's Expanded Emergency Use Approval for Antibody Therapy to Treat COVI..
03/12FDA Expands Emergency Use for Lilly Antibody Combination for Covid-19 to Include Infant..
03/12Eli Lilly Sees FDA Granting EUA of Two Monoclonal Antibodies for Treatment of COVID in ..
03/12AbCellera Biologics Names New Chief Commercial Officer
03/12Eli Lilly, Innovent Biologics' Cancer Drug Added to China's Updated National Reimbursem..
03/12Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LL..
03/12Innovent Biologics, Inc. and Eli Lilly and Company Announce Successful Expansion of Sin..
02/12Special Report-U.S. rushed contracts to COVID-19 suppliers with troubled plants
02/12What COVID-19 vaccine and drug makers have to say about Omicron
01/12Lilly to Announce Initial 2022 Financial Guidance; Provide R&D Overview at Investment C..
30/11US Stocks Slump as Omicron Variant, Fed Chief's Comment on Faster Asset Purchase Taperi..
30/11CLOSE UPDATE : US Stocks See Sharp Decline as Omicron Variant, Fed Chief Comment on Faster..
30/11Equities Drop Midday as Moderna CEO Questions COVID-19 Vaccines' Efficacy Against Omicr..
30/11MIDDAY REPORT : US Stocks Drop as Moderna CEO Questions COVID-19 Vaccines' Efficacy Agains..
30/11Regeneron's COVID-19 antibody drug may be less effective against Omicron
18/11Emgality Versus Nurtec ODT Head-To-Head Migraine Preventive Treatment Study Now Enrolli..
18/11Fountain Therapeutics Inc. announced that it has received $15.864168 million in funding..
17/11Lilly to Participate in Fourth Annual Evercore ISI HealthCONx Conference
17/11PharmStars Announces Showcase Event for Inaugural Class
16/11Fountain Therapeutics Inc. announced that it expects to receive $15.864168 million in f..
12/11REFILE-UPDATE 4-Biden will nominate industry-friendly Califf to lead U.S. FDA
12/11Dicerna Pharmaceuticals to Receive Multimillion-Dollar Milestone Payments Under Collabo..
12/11Lilly to supply 614,000 additional doses of abcellera, discovered bamlanivimab together..
12/11DICERNA PHARMA : Two Targets in Lilly Collaboration Meet Proof of Principle
12/11Dicerna Pharmaceuticals, Inc. Announces Two Targets Meet Preclinical Proof of Principle..
11/11Health Care Down As Traders Hedge On Growth View -- Health Care Roundup
11/11Eli Lilly, Boehringer's Heart Drug Jardiance Gets Priority Review from FDA
11/11US FDA accepts supplemental New Drug Application and grants Priority Review for Jardian..
11/11Boehringer Ingelheim and Eli Lilly and Company Announces US FDA Accepts Supplemental Ne..
11/11District Courts Issue Key Decisions In 340B Contract Pharmacy Cases
09/11Lilly to Participate in Wolfe Research Virtual Healthcare Conference
03/11EU-Arzneimittelbehörde stoppt Prüfung von Covid-Medikament von Eli Lilly
02/11Eli Lilly to Supply COVID-19 Medication Worth $1.29 Billion as Part of Additional US Go..
02/11Eli Lilly Withdraws From European Medicines Agency's Rolling Review Process for COVID-1..
02/11Monetary policy starts to change
02/11Eli Lilly to Supply $1.29 Billion Worth of COVID-19 Medication as Part of Additional US..
02/11CORONA-BLOG/USA bestellen bei Eli Lilly Covid-Arznei für 1,29 Mrd Dollar
02/11Eli Lilly Gets $1.29 Billion U.S. Order for Covid-19 Cocktail
02/11U.S. buys more doses of Lilly's COVID-19 treatment for $1.29 bln
02/11U.S. buys more doses of Lilly's COVID-19 treatment for $1.29 bln
02/11Eli Lilly and Company to Supply 614,000 Additional Doses of Bamlanivimab and Etesevimab..
01/11Lilly to Participate in Bernstein's Second Annual Operational Decisions Conference
28/10Additional Verzenio® (abemaciclib) Phase 3 monarchE Trial Data Published in the Annals ..
27/10ELI LILLY & CO Management's Discussion and Analysis of Results of Operations and Finan..
26/10MÄRKTE USA/Überzeugende Berichtssaison sorgt für neue Rekordstände
26/10MÄRKTE USA/Rekordjagd hält an - Berichtssaison überzeugt weiter
26/10Eli Lilly Reports Higher Third-Quarter Results, Raises 2021 Forecast to Reflect Increas..
26/10MÄRKTE USA/Wall Street startet mit neuen Rekordhochs
26/10GLOBAL MARKETS LIVE : Michelin, Facebook, UBS, Tesla, Volvo...
26/10Eli Lilly Intends to Complete US Marketing Application Submission for Alzheimer's Drug ..
26/10Eli Lilly Alzheimer's Programs Head in Different Directions
26/10Eli Lilly wächst auch im dritten Quartal deutlich
26/10Health Care Stocks Edge Higher Premarket Tuesday
26/10Eli Lilly, Pfizer Halt Program for Osteoarthritis Pain Drug
26/10MÄRKTE USA/Wall Street zum Start mit Aufschlägen erwartet
26/10Lilly kicks off application for Alzheimer's drug U.S. approval, ups outlook
26/10Are companies fooling themselves on inflation?
26/10Lilly Cuts Income Targets, Lifts Sales Forecast For FY21
26/10Lilly Reports Robust Third-Quarter 2021 Financial Results as Pipeline Success Strengthe..
26/10Eli Lilly past outlook aan
26/10Q3 2021 Lilly Press Release
26/10Eli Lilly Posts Higher Q3 Adjusted EPS, Revenue; Boosts 2021 Guidance
26/10LILLY : Q3 Earnings Snapshot
26/10Earnings Flash (LLY) ELI LILLY AND COMPANY Reports Q3 Revenue $6.77B, vs. Street Est of..
26/10GUIDANCE : (LLY) ELI LILLY AND COMPANY Expects Fiscal Year 2021 EPS Range $7.95 - $8.05
26/10Lilly Reports Robust Third-Quarter 2021 Financial Results as Pipeline Success Strengthe..
26/10Earnings Flash (LLY) ELI LILLY AND COMPANY Reports Q3 EPS $1.94, vs. Street Est of $1.9..
26/10Eli Lilly and Company Revises Earnings Guidance for the Full Year 2021
26/10EARNINGS REACTION HISTORY : Eli Lilly and Co, 33.3% Follow-Through Indicator, 2.2% Sensiti..
26/10Eli Lilly, Pfizer End Program for Tanezumab Pain Drug
26/10Eli Lilly Moves Forward With Diabetes, Alzheimer's Drugs
26/10Tesla y Facebook en modo fuego cruzado
26/10Tranche Update on Eli Lilly and Company's Equity Buyback Plan announced on July 24, 201..
1  2  3  4  5  6  7  8  9  10Suiv.